人工智能在口腔潜在恶性疾病中的应用:当前观点和未来障碍。

IF 2.5 3区 医学 Q2 ONCOLOGY
Xuze Guo, Yaozu He, Qi Han, Jialin Xie, Yi Jia, You Li, Fanglong Wu
{"title":"人工智能在口腔潜在恶性疾病中的应用:当前观点和未来障碍。","authors":"Xuze Guo, Yaozu He, Qi Han, Jialin Xie, Yi Jia, You Li, Fanglong Wu","doi":"10.1007/s12094-025-04043-4","DOIUrl":null,"url":null,"abstract":"<p><p>Oral potentially malignant disorders (OPMDs) refer to oral mucosal disorders with an increased risk of malignancy, primarily oral squamous cell carcinoma (OSCC), especially in South and Southeast Asia. Since not all patients with OPMDs develop oral cancer, accurate early detection and diagnosis of malignant transformation are critically important for clinicians to determine the optimal therapeutic approach. Therefore, distinguishing OPMDs from early-stage OSCC is an increasing challenge in the clinic. Artificial intelligence (AI) technology has recently been shown to quickly identify high-risk conditions/lesions for screening oral cancer early. Moreover, the AI algorithm can also be used to determine the prognosis of OPMDs. In this review, we systematically summarize the medical records, oral images, pathological examinations, biomarkers, omics data and other aspects of the main outcomes of AI applied to address OPMDs-related issues. Furthermore, we discuss automated diagnostic systems and risk prediction tools for malignant transformation with pleasant outcomes and the potential to ultimately assist clinicians. Finally, we introduce the current challenges and barriers to AI in OPMDs on the premise that more advanced AI models and larger datasets will lead to the use of AI models in OPMDs.</p>","PeriodicalId":50685,"journal":{"name":"Clinical & Translational Oncology","volume":" ","pages":""},"PeriodicalIF":2.5000,"publicationDate":"2025-08-30","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"Application of artificial intelligence in oral potentially malignant disorders: current opinions and future barriers.\",\"authors\":\"Xuze Guo, Yaozu He, Qi Han, Jialin Xie, Yi Jia, You Li, Fanglong Wu\",\"doi\":\"10.1007/s12094-025-04043-4\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"<p><p>Oral potentially malignant disorders (OPMDs) refer to oral mucosal disorders with an increased risk of malignancy, primarily oral squamous cell carcinoma (OSCC), especially in South and Southeast Asia. Since not all patients with OPMDs develop oral cancer, accurate early detection and diagnosis of malignant transformation are critically important for clinicians to determine the optimal therapeutic approach. Therefore, distinguishing OPMDs from early-stage OSCC is an increasing challenge in the clinic. Artificial intelligence (AI) technology has recently been shown to quickly identify high-risk conditions/lesions for screening oral cancer early. Moreover, the AI algorithm can also be used to determine the prognosis of OPMDs. In this review, we systematically summarize the medical records, oral images, pathological examinations, biomarkers, omics data and other aspects of the main outcomes of AI applied to address OPMDs-related issues. Furthermore, we discuss automated diagnostic systems and risk prediction tools for malignant transformation with pleasant outcomes and the potential to ultimately assist clinicians. Finally, we introduce the current challenges and barriers to AI in OPMDs on the premise that more advanced AI models and larger datasets will lead to the use of AI models in OPMDs.</p>\",\"PeriodicalId\":50685,\"journal\":{\"name\":\"Clinical & Translational Oncology\",\"volume\":\" \",\"pages\":\"\"},\"PeriodicalIF\":2.5000,\"publicationDate\":\"2025-08-30\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Clinical & Translational Oncology\",\"FirstCategoryId\":\"3\",\"ListUrlMain\":\"https://doi.org/10.1007/s12094-025-04043-4\",\"RegionNum\":3,\"RegionCategory\":\"医学\",\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"Q2\",\"JCRName\":\"ONCOLOGY\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Clinical & Translational Oncology","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.1007/s12094-025-04043-4","RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q2","JCRName":"ONCOLOGY","Score":null,"Total":0}
引用次数: 0

摘要

口腔潜在恶性疾病(OPMDs)是指具有恶性肿瘤风险增加的口腔黏膜疾病,主要是口腔鳞状细胞癌(OSCC),特别是在南亚和东南亚。由于并非所有opmd患者都会发展为口腔癌,因此准确的早期发现和诊断恶性转化对于临床医生确定最佳治疗方法至关重要。因此,在临床上区分opmd和早期OSCC是一个越来越大的挑战。人工智能(AI)技术最近被证明可以快速识别高危条件/病变,以便早期筛查口腔癌。此外,人工智能算法还可以用于确定opmd的预后。在这篇综述中,我们系统地总结了人工智能应用于解决opmds相关问题的病历、口腔图像、病理检查、生物标志物、组学数据等方面的主要结果。此外,我们讨论了恶性转化的自动诊断系统和风险预测工具,这些工具具有令人愉快的结果和最终协助临床医生的潜力。最后,我们介绍了人工智能在opmd中目前面临的挑战和障碍,前提是更先进的人工智能模型和更大的数据集将导致人工智能模型在opmd中的使用。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
Application of artificial intelligence in oral potentially malignant disorders: current opinions and future barriers.

Oral potentially malignant disorders (OPMDs) refer to oral mucosal disorders with an increased risk of malignancy, primarily oral squamous cell carcinoma (OSCC), especially in South and Southeast Asia. Since not all patients with OPMDs develop oral cancer, accurate early detection and diagnosis of malignant transformation are critically important for clinicians to determine the optimal therapeutic approach. Therefore, distinguishing OPMDs from early-stage OSCC is an increasing challenge in the clinic. Artificial intelligence (AI) technology has recently been shown to quickly identify high-risk conditions/lesions for screening oral cancer early. Moreover, the AI algorithm can also be used to determine the prognosis of OPMDs. In this review, we systematically summarize the medical records, oral images, pathological examinations, biomarkers, omics data and other aspects of the main outcomes of AI applied to address OPMDs-related issues. Furthermore, we discuss automated diagnostic systems and risk prediction tools for malignant transformation with pleasant outcomes and the potential to ultimately assist clinicians. Finally, we introduce the current challenges and barriers to AI in OPMDs on the premise that more advanced AI models and larger datasets will lead to the use of AI models in OPMDs.

求助全文
通过发布文献求助,成功后即可免费获取论文全文。 去求助
来源期刊
CiteScore
6.20
自引率
2.90%
发文量
240
审稿时长
1 months
期刊介绍: Clinical and Translational Oncology is an international journal devoted to fostering interaction between experimental and clinical oncology. It covers all aspects of research on cancer, from the more basic discoveries dealing with both cell and molecular biology of tumour cells, to the most advanced clinical assays of conventional and new drugs. In addition, the journal has a strong commitment to facilitating the transfer of knowledge from the basic laboratory to the clinical practice, with the publication of educational series devoted to closing the gap between molecular and clinical oncologists. Molecular biology of tumours, identification of new targets for cancer therapy, and new technologies for research and treatment of cancer are the major themes covered by the educational series. Full research articles on a broad spectrum of subjects, including the molecular and cellular bases of disease, aetiology, pathophysiology, pathology, epidemiology, clinical features, and the diagnosis, prognosis and treatment of cancer, will be considered for publication.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术官方微信